To begin to elucidate what pathological mechanism(s) (e.g., Aβ vs. Tau) impact ITSN1 changes in AD, we evaluated ITSN1 levels in the 5xFAD mouse model over the lifespan. This evidence concerns the gene MAPT and Alzheimer disease.